Designed to support the safe and effective use of medicines, Risk Management Programs (RMP) ensure that healthcare professionals, patients, and caregivers can access tailored education materials. These materials provide clear information about the risks associated with medicine use and how to manage them for the best treatment outcomes.
It's important to note that these materials are not a duplicate of Production Information (PI) or Consumer Medicine Information (CMI), and may not be available for all medicines.
Mayzent education materials for healthcare professionals can be accessed below. This information is specifically for use in Australia and should not replace advice from a healthcare professional.
For further questions or concerns, please contact Novartis Medical Information at 1800 671 203.